Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Outcome Measure:

molecular alteration in breast cancer

Outcome Description:

gene expression level

Outcome Time Frame:

average of 4 weeks after diagnosis

Safety Issue:

No

Principal Investigator

Carole TARPIN, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Institut Paoli-Calmettes

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

BC-BIO/IPC 2009-005

NCT ID:

NCT01521676

Start Date:

December 2010

Completion Date:

Related Keywords:

• Breast Cancer
• breast cancer
• Breast Neoplasms

Name	Location